跳至主要内容
临床试验/NCT02991729
NCT02991729已完成不适用

Use of a Novel Decision Aid for Prenatal Aneuploidy Screening

University of North Carolina, Chapel Hill2 个研究点 分布在 1 个国家目标入组 197 人开始时间: 2017年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
197
试验地点
2
主要终点
Knowledge Score

研究概览

简要总结

The investigators aim to assess whether use of a novel, tablet-based computerized decision aid for aneuploidy screening is similar to routine care with a brief genetic counseling visit in improving patient knowledge and decreasing decisional conflict.

详细描述

184 women will be randomized in a 1:1 fashion to use of a novel computerized iPad-based decision aid in addition to routine counseling or routine counseling only during a single study visit. This decision aid was developed at a 10th grade literacy level using input from Maternal Fetal Medicine physicians and certified genetic counselors, and piloted by 20 English and Spanish speaking women of varying education levels. Following completion of genetic counseling, participants will complete several surveys assessing knowledge and decision conflict. Data will be abstracted regarding demographics, screening and diagnostic testing uptake, and testing results.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnancy at less than 22 weeks gestation
  • English or Spanish speaking
  • Undergoing genetic counseling at North Carolina Women's Hospital for aneuploidy screening

排除标准

  • Known fetal anomalies
  • Known multiple gestations
  • Prior genetic counseling or aneuploidy screening in current pregnancy

结局指标

主要结局

Knowledge Score

时间窗: At completion of genetic counseling for the Routine Care Group and at completion of decision aid and genetic counseling for Experimental Group, approximately 10-60 minutes

All patients in the intervention arm will complete a knowledge questionnaire following completion of the decision and and again immediately following genetic counseling. The investigators will assess noninferiority of the decision aid on participant knowledge, with primary outcome comparing knowledge after completion of the decision aid in the intervention arm, to knowledge following genetic counseling only in the routine care arm. The questionnaire is a modification of the validated Maternal Serum Screening Knowledge Questionnaire. This is on a 12-point scale (values 0-12), with higher score indicating greater knowledge.

次要结局

  • Decisional Conflict Score(At completion of decision aid (Experimental group) and completion of genetic counseling (all participants), approximately 10-60 minutes)
  • Test Chosen(At completion of decision aid and at completion genetic counseling, approximately 10-60 minutes)
  • Supplementary Tests Performed(22 weeks gestation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验